128184-01-0

Basic information

• Product Name: 4-Bromo-2,6-diformylpyridine
• Synonyms: 4-Bromo-2,6-diformylpyridine;4-Bromo-2,6-pyridinedicarboxaldehyde
• CAS NO: 128184-01-0
• Molecular Formula: C₇H₄BrNO₂
• Molecular Weight: 214.02
• Product Categories: pharmacetical;Pyridines
• Mol File: 128184-01-0.mol

Chemical Properties

• Boiling Point: 294.035°C at 760 mmHg
• Flash Point: 131.628°C
• Appearance: /
• Density: 1.752g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.668
• PKA: -0.10±0.10(Predicted)
• CAS DataBase Reference: 4-Bromo-2,6-diformylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-2,6-diformylpyridine(128184-01-0)
• EPA Substance Registry System: 4-Bromo-2,6-diformylpyridine(128184-01-0)

Safety Data

• Hazardous Substances Data: 128184-01-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C7H4BrNO2/c8-5-1-6(3-10)9-7(2-5)4-11/h1-4H

Upstream product

• 120491-88-5 4-bromo-2,6-pyridinedimethanol 
• 499-51-4 Chelidamic acid 
• 162102-79-6 dimethyl 4-bromo-2,6-pyridinedicarboxylate 
• 162102-81-0 4-bromopyridine-2,6-dicarboxylic acid 
• 120491-93-2 4-bromopyridine-2,6-dicarbonyl dibromide 
• 1422463-81-7 4-bromo-2,6-bis(1-pyrrolidinylcarbonyl)pyridine 
• 138-60-3 chelidamic acid 

Downstream Products

• 128184-04-3 4-(phenylethynyl)-2,6-diformylpyridine 
• 1364054-76-1 3,3'-[4-(4-chlorophenyl)pyridine-2,6-diyl]dipropanoic acid 
• 1364054-33-0 dimethyl (2E,2'E)-3,3'-[4-(4-chlorophenyl)pyridine-2,6-diyl]bisprop-2-enoate 
• 1364054-49-8 dimethyl 3,3'-[4-(4-chlorophenyl)pyridine-2,6-diyl]dipropanoate 
• 717124-11-3 4-phenylpyridine-2,6-dicarboxaldehyde 
• 1609985-98-9 C₃₃H₂₅N₃O₆ 
• 1620511-30-9 4-(4-methoxyphenyl)pyridine-2,6-dicarbaldehyde 
• 1620511-33-2 C₁₃H₇F₂NO₂ 
• 128184-08-7 (7,11-Bis-tert-butoxycarbonylmethyl-15-phenylethynyl-3,7,11,17-tetraaza-bicyclo[11.3.1]heptadeca-1⁽¹⁶⁾,13⁽¹⁷⁾,14-trien-3-yl)-acetic acid tert-butyl ester 
• 128184-02-1 15-(phenylethynyl)-3,7,11-tris(carboxymethyl)-3,7,11,17-tetraazabicyclo<11.3.1>heptadeca-1(17),13,15-triene 

Relevant articles and documents

COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS

The present invention relates to compounds as defined herein, which are activators of long form cyclic nucleotide phosphodiesterase-4 (PDE4) enzymes (isoforms) and to therapies using these activators. In particular, the invention relates to these activator compounds for use in a method for the treatment or prevention of disorders requiring a reduction of second messenger responses mediated by cyclic 3',5-adenosine monophosphate (cAMP).

Azobenzene-Equipped Covalent Organic Framework: Light-Operated Reservoir

Light-operated materials have gained significant attention for their potential technological importance. To achieve molecular motion within extended networks, stimuli-responsive units require free space. The majority of the so far reported 2D-extended org

Formation of a hetero[3]rotaxane by a dynamic component-swapping strategy

Acid-catalysed scrambling of the mechanically interlocked components between two different homo[3]rotaxanes, constituted of dumbbells containing two secondary dialkylammonium ion recognition sites encircled by two [24]crown-8 rings, each containing a couple of imine bonds, affords a statistical mixture of a hetero[3]rotaxane along with the two homo[3]rotaxanes, indicating that neither selectivity nor cooperativity is operating during the assembly process. This journal is the Partner Organisations 2014.

A convenient approach for the synthesis of 2,6-diformyl- and 2,6-diacetylpyridines

2,6-Diformyl- and 2,6-diacetylpyridines are readily accessed in good yields (60-90%) via the single-pot reaction of 2,6-pyridine dicarboxamides with LiAlH4 or MeMgCl in THF at 0-20°C. The high efficiency of the method illustrates the significance of solubility in the reduction and alkylation of difunctionalized substrates.

A mitochondria-targeted macrocyclic Mn(II) superoxide dismutase mimetic

Superoxide (O2s-) is the proximal mitochondrial reactive oxygen species underlying pathology and redox signaling. This central role prioritizes development of a mitochondria-targeted reagent selective for controlling O2s-. We have conjugated a mitochondria-targeting triphenylphosphonium (TPP) cation to a O2 s--selective pentaaza macrocyclic Mn(II) superoxide dismutase (SOD) mimetic to make MitoSOD, a mitochondria-targeted SOD mimetic. MitoSOD showed rapid and extensive membrane potential-dependent uptake into mitochondria without loss of Mn and retained SOD activity. Pulse radiolysis measurements confirmed that MitoSOD was a very effective catalytic SOD mimetic. MitoSOD also catalyzes the ascorbate-dependent reduction of O2s-. The combination of mitochondrial uptake and O2s- scavenging by MitoSOD decreased inactivation of the matrix enzyme aconitase caused by O2s-. MitoSOD is an effective mitochondria-targeted macrocyclic SOD mimetic that selectively protects mitochondria from O2s- damage.

Template-directed synthesis of multiply mechanically interlocked molecules under thermodynamic control

The template-directed construction of crown-ether-like macrocycles around secondary dialkylammonium ions (R2NH2+) has been utilized for the expedient (one-pot) and high-yielding synthesis of a diverse range of mechanically

Mitochondrially targeted antioxidants

The invention provides mitochondrially targeted antioxidant compounds comprising a lipophilic cation moiety covalently coupled to an antioxidant moiety which is either a superoxide dismutase (SOD) mimetic or a glutathione peroxidase mimetic. These compoun

Preparation of New Macrocyclic Polyamines Containing 4-(Phenylethynyl)pyridine Subunit

Two new tetraazacycloalkane-N-acetic acids containing 4-(phenylethynyl)pyridine subunit as a part of macrocycle have been prepared.Two methods for the cyclisation reaction were investigated.